Go to the list of all blogs
Allana's Avatar
published in Blogs
Nov 15, 2026
TickeronGET DAILY SIGNALS
Goldman Sachs (GS) Advances +4% on Strong Q3 Trading and Advisory Gains

Goldman Sachs (GS) Advances +4% on Strong Q3 Trading and Advisory Gains

Key Takeaways

  • Goldman Sachs (GS) shares have risen roughly 4% over the past 30 days, moving from about $881 to around $917, even as the stock trades well below its 52-week high.
  • Third-quarter 2026 net revenue rose 23% year over year to $18.68 billion, the firm's second-highest quarterly result, with diluted EPS of $17.01 up 39%.
  • Equities revenue jumped 72% year over year to $6.44 billion, while investment banking fees climbed 21% on record advisory activity.
  • Asset & Wealth Management revenue rose 14% to $5.05 billion, with assets under supervision reaching a record $4.1 trillion.
  • Platform Solutions revenue fell 72% to $170 million, reflecting markdowns tied to the Apple Card loan portfolio.
  • Investors continue to debate whether cyclical trading strength is durable against the firm's ongoing shift toward recurring, fee-based revenue.

Recent Price Movement in GS

Goldman Sachs shares have traded in a relatively contained range over the past month, advancing about 4% from roughly $881.26 in mid-October to around $916.56 in mid-November. That move keeps the stock well below its 52-week high near $1,154, within a broader 52-week range that has spanned approximately $754 to $1,154. The modest monthly gain follows a strong third-quarter earnings report that briefly lifted shares before trading settled into a more measured pattern, reflecting a market that is weighing robust near-term results against questions about how sustainable the current revenue mix will prove.

Goldman Sachs Business Overview and Position

The Goldman Sachs Group, Inc., founded in 1869, is a leading global investment bank and financial services firm. The company operates primarily through three segments: Global Banking & Markets, Asset & Wealth Management, and Platform Solutions. Its core activities include investment banking advisory and underwriting, market making and trading across equities and fixed income, lending, asset management, and wealth management. Goldman has held the top position in global mergers and acquisitions advisory by revenue for two decades, and since the global financial crisis it has increasingly emphasized more predictable, fee-based businesses such as asset and wealth management to diversify beyond cyclical trading and deal activity. Investors follow the stock closely because of its sensitivity to capital-markets activity, interest rates, and broader economic conditions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Key Drivers from the Latest Quarter

The most significant recent catalyst was the firm's third-quarter 2026 earnings release. Net revenue reached $18.68 billion, up 23% year over year, and diluted earnings per share of $17.01 beat consensus estimates by a wide margin. The Global Banking & Markets segment led the gains, with revenue up 32% to $13.46 billion. Equities revenue surged 72% to $6.44 billion on stronger financing and derivatives activity, while investment banking fees rose 21% to $3.22 billion, including a record $1.65 billion in advisory revenue. Fixed income, currencies, and commodities revenue was essentially flat at $3.47 billion.

Asset & Wealth Management revenue increased 14% to $5.05 billion, supported by record management and other fees and a 35th consecutive quarter of long-term net inflows, pushing assets under supervision to a record $4.1 trillion. Partly offsetting these strengths, Platform Solutions revenue declined 72% to $170 million because of markdowns on the Apple Card loan portfolio, which was previously moved to held-for-sale status. Operating expenses rose 20% to $11.31 billion, and the provision for credit losses increased to $368 million. The firm's annualized return on equity reached 18.7%, and its board declared a quarterly dividend of $5.00 per share.

2026 Outlook and Areas to Monitor

Looking ahead, investors are likely to focus on whether the strength in equities trading and investment banking carries into future quarters, given that these revenue streams are inherently cyclical. Management has indicated that fourth-quarter incentive fees are expected to remain elevated and that the full-year effective tax rate is projected near 20%, potentially lower if certain tax audits are resolved. Full-year alternatives fundraising is targeted at roughly $150 billion. Longer-term, the firm's medium-term goals for Asset & Wealth Management include a 17% to 19% return on equity, an approximately 30% pre-tax margin, $750 billion in alternative assets under supervision by 2030, and $300 billion in credit alternative assets by 2028. Key risks to monitor include a potential normalization in trading activity, a declining investment banking fee backlog, wholesale credit impairments, interest-rate movements, and regulatory developments.

Using AI Tools for Additional Perspective

In reviewing the data around Goldman Sachs, I turned to Tickeron’s AI Trading Bots to explore algorithmic strategies that align with the current market environment. These tools provide a range of approaches based on different timeframes and performance metrics, helping to identify ideas that complement fundamental analysis without replacing it.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GS

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


GS's RSI Oscillator climbs out of oversold territory

The RSI Indicator for GS moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 18 of the 22 cases the stock moved higher. This puts the odds of a move higher at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on GS as a result. In 57 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

The Moving Average Convergence Divergence (MACD) for GS just turned positive on October 12, 2026. Looking at past instances where GS's MACD turned positive, the stock continued to rise in 27 of 45 cases over the following month. The odds of a continued upward trend are 60%.

Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where GS advanced for three days, in 212 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

GS moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

GS broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GS entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 4 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. GS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.298) is normal, around the industry mean (3.120). P/E Ratio (13.194) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (1.133) is also within normal values, averaging (0.809). Dividend Yield (0.023) settles around the average of (8.976) among similar stocks. P/S Ratio (4.394) is also within normal values, averaging (16.899).

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 11.48B. The market cap for tickers in the group ranges from 590 to 284.96B. MS holds the highest valuation in this group at 284.96B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was -2%. For the same Industry, the average monthly price growth was -17%, and the average quarterly price growth was -26%. CANG experienced the highest price growth at 52%, while DOMH experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was -19%. For the same stocks of the Industry, the average monthly volume growth was -23% and the average quarterly volume growth was -44%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 66
Price Growth Rating: 69
SMR Rating: 74
Profit Risk Rating: 87
Seasonality Score: -6 (-100 ... +100)
Paper Trades 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of investment banking, securities and asset management services

Industry InvestmentBanksBrokers

Industry
Investment Banks Or Brokers
Address
200 West Street
Phone
+1 212 902-1000
Employees
47400
Web
https://www.goldmansachs.com
Interact to see
Advertisement
The central price target used here is $400 , roughly 35% above Alphabet's latest verified closing price of $295.77 (November 13, 2026). This target is the arithmetic mean of verified analyst price targets reviewed, not a single analyst's forecast; independent data providers report comparable consensus averages in the high-$390s to low-$400s.
Upcoming catalysts: Integration of advertising into AI Overviews and Gemini conversations, the scaling of Gemini 3 and newer models across Search and Cloud, and the commercial ramp of the $32 billion Wiz cloud-security acquisition could all shape sentiment into 2026. Strategic positioning: Alphabet's vertically integrated artificial intelligence (AI) stack — from custom TPU (Tensor Processing Unit) chips to the Gemini models to Google Cloud — supports a durable, cost-advantaged position in the AI build-out.
The TETH exchange-traded fund (ETF) is the 21Shares Ethereum Staking ETF, a spot Ethereum fund listed on Cboe BZX, and it does not carry conventional analyst price targets. The $14 objective used here is a technical milestone discussed in public market commentary — roughly the zone where Ethereum could begin confirming a recovery — not an analyst consensus.
The central target of $6.70 is the arithmetic mean of seven recent, individually verified analyst price targets, rounded from $6.67. At a latest price near $3.70, reaching $6.70 would require roughly 81% upside — a very large move.
Lead catalyst: Chemomab has secured alignment with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on a single Phase 3 registration trial for nebokitug in primary sclerosing cholangitis (PSC), a rare liver disease with no approved disease-modifying therapy. Strategic pivot: A planned merger with Scipher Medicine is expected to close by year-end 2026, extending nebokitug into an AI-powered, precision-medicine Phase 2 trial in rheumatoid arthritis (RA).